TNGX
Tango Therapeutics Inc
25.50$
+14.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.28 | 0.80 | -0.96 | -1.24 | -1.25 | -1.20 | -1.20 | |
| 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | |
| 0.02 | 0.02 | 0.13 | 0.16 | 0.20 | 0.26 | 0.23 | |
| 0.02 | 0.03 | 0.15 | 0.15 | – | – | – | |
| 0.02 | 1.36 | -0.18 | -0.21 | -0.40 | -0.29 | -0.58 | |
| 0.02 | 0.01 | 0.03 | 0.09 | 0.02 | 0.01 | 0.01 | |
| 0.01 | -1.66 | -2.95 | 0.30 | 0.44 | 0.79 | -0.35 | |
| – | – | 0.50 | – | – | – | – | |
| – | – | 5.51 | 0.00 | – | – | – | |
| 0.13 | 0.92 | 5.75 | 0.02 | 0.87 | 0.44 | 1.92 | |
| 0.29 | 0.06 | 1.84 | -0.92 | 0.06 | 0.02 | 0.37 | |
| -0.30 | 0.79 | -0.99 | -1.33 | -1.26 | -1.21 | -1.20 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.